Gardasil Advisory Cmte. Has Advice On Marketing, Not Just PostMarket Trials

Merck remains on track towards adding the genital warts indication for its Gardasil human papillomavirus vaccine for use by males 9-26 years old following favorable votes on efficacy (7-0, with 1 abstention) and safety (7-1) at FDA's Vaccines & Related Biological Products Advisory Committee on September 9